Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

VIJENDRA SWARUP

Allopathic & Osteopathic Physicians Internal Medicine Clinical Cardiac Electrophysiology

NPI
1427051929
CMS profile
19622
Location
PHOENIX, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$11,210.98

211 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $7,170.40 200
Consulting Fee $2,200.00 1
Travel and Lodging $1,826.69 9
Education $13.89 1

By paying entity

PY2022 · entire year · sorted by reported total

Page 3 of 5; records 101–150 of 211 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

VIJENDRA SWARUP

NPI 1427051929 · CMS profile ID 19622

Allopathic & Osteopathic Physicians / Internal Medicine / Clinical Cardiac Electrophysiology

PHOENIX, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 5; records 101–150 of 211 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1427051929?year=2022&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
VIJENDRA SWARUP, NPI 1427051929, CMS profile ID 19622. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 5; records 101–150 of 211 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1427051929?year=2022&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). VIJENDRA SWARUP, NPI 1427051929, CMS profile ID 19622. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 5; records 101–150 of 211 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1427051929?year=2022&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
VIJENDRA SWARUP, NPI 1427051929, CMS profile ID 19622, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 5; records 101–150 of 211 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1427051929?year=2022&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

211 matching records · $11,210.98 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 211 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 211.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Impulse Dynamics (USA) Inc. $10.3707/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 947559079 CMS
Novartis Pharmaceuticals Corporation $19.4807/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894408243 CMS
Abbott Laboratories $17.9806/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914203579 CMS
Abbott Laboratories $129.1506/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914203607 CMS
Abbott Laboratories $12.2806/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914203615 CMS
Abbott Laboratories $15.5506/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920465921 CMS
Biosense Webster, Inc. $10.0006/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887018349 CMS
Merck Sharp & Dohme LLC $14.2406/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944302087 CMS
Novartis Pharmaceuticals Corporation $18.8206/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894408229 CMS
SANOFI-AVENTIS U.S. LLC $43.5906/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938895215 CMS
Biosense Webster, Inc. $11.6806/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887018395 CMS
Novartis Pharmaceuticals Corporation $18.0106/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894408237 CMS
AstraZeneca Pharmaceuticals LP $18.9006/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914962795 CMS
Abbott Laboratories $16.6906/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920465853 CMS
Abbott Laboratories $17.0706/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920465865 CMS
Abbott Laboratories $18.4106/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920465871 CMS
Abbott Laboratories $137.8306/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920465899 CMS
Abbott Laboratories $190.6306/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920465909 CMS
Impulse Dynamics (USA) Inc. $3.2606/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 947559055 CMS
Impulse Dynamics (USA) Inc. $14.6606/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 947561043 CMS
Novartis Pharmaceuticals Corporation $8.5506/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894408223 CMS
Janssen Pharmaceuticals, Inc $9.4806/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885708171 CMS
Merck Sharp & Dohme LLC $15.6806/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944174825 CMS
Novartis Pharmaceuticals Corporation $16.1506/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894408235 CMS
Boston Scientific Corporation $2,200.0005/27/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 916596787 CMS
Abbott Laboratories $94.9905/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920465887 CMS
Acutus Medical, Inc. $55.1805/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 963835793 CMS
Biosense Webster, Inc. $10.4505/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887018327 CMS
Novartis Pharmaceuticals Corporation $19.2505/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894408233 CMS
Boston Scientific Corporation $85.4805/14/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 916598363 CMS
Boston Scientific Corporation $181.8905/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 916598369 CMS
Boston Scientific Corporation $229.3205/14/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 916598373 CMS
Boston Scientific Corporation $272.5205/13/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 916596783 CMS
Boston Scientific Corporation $303.5605/13/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 916596785 CMS
Boston Scientific Corporation $57.1905/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 916598361 CMS
Boston Scientific Corporation $96.6605/13/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 916598365 CMS
Boston Scientific Corporation $170.0005/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 916598367 CMS
Merck Sharp & Dohme LLC $14.0905/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944150663 CMS
CARDIVA MEDICAL, INC. $14.1605/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 955373609 CMS
Janssen Pharmaceuticals, Inc $9.4805/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885708189 CMS
Novartis Pharmaceuticals Corporation $19.2405/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894408227 CMS
Abbott Laboratories $78.0805/05/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920465057 CMS
Abbott Laboratories $348.6805/05/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920465061 CMS
Abbott Laboratories $402.7205/05/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920465067 CMS
Abbott Laboratories $100.3905/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920465893 CMS
PFIZER INC. $13.1105/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949147031 CMS
Biosense Webster, Inc. $180.8505/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887017595 CMS
Boston Scientific Corporation $183.9804/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 916598371 CMS
SANOFI-AVENTIS U.S. LLC $36.7904/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938895195 CMS
Novartis Pharmaceuticals Corporation $104.8904/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894408211 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $59,454.97 253
PY2020 $64,586.64 316
PY2021 $17,483.62 274
PY2022 $11,210.98 211
PY2023 $10,650.15 184
PY2024 $16,219.76 213
PY2025 $7,763.14 179

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $911,495.37 26
PY2024 Recipient $1,637.21 2
PY2024 Principal investigator $1,205,543.28 70
PY2023 Principal investigator $889,922.63 66
PY2022 Principal investigator $203,132.24 58
PY2021 Principal investigator $348,407.39 59
PY2020 Principal investigator $352,923.62 77
PY2019 Principal investigator $1,006,151.51 94

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

26 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Janssen Research & Development, LLC $28,192.00 12/12/2025 Non-covered Recipient Entity
Arizona Crdvsclr Rsrch Fndtn
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175165182
Principal investigator 1 Boston Scientific Corporation $3,608.57 11/25/2025 Non-covered Recipient Entity
ARIZONA CARDIOVASCULAR RESEARCH FOUNDATION
CHAMPION-AF No dispute reported 06/30/2026 1207571129
Principal investigator 1 Janssen Research & Development, LLC $73,771.00 11/19/2025 Non-covered Recipient Entity
Arizona Crdvsclr Rsrch Fndtn
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175166130
Principal investigator 1 Janssen Research & Development, LLC $70,230.00 11/07/2025 Non-covered Recipient Entity
Arizona Crdvsclr Rsrch Fndtn
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175165813
Principal investigator 1 Janssen Research & Development, LLC $3,696.00 11/03/2025 Non-covered Recipient Entity
Arizona Crdvsclr Rsrch Fndtn
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175165269
Principal investigator 1 Boston Scientific Corporation $650.00 10/28/2025 Non-covered Recipient Entity
ARIZONA CARDIOVASCULAR RESEARCH FOUNDATION
CHAMPION-AF No dispute reported 06/30/2026 1207571127
Principal investigator 1 Abbott Laboratories $1,881.00 10/22/2025 Non-covered Recipient Entity
Arizona Arrhythmia Research Center
NCT04226547--Amplatzer Amulet LAAO vs. NOAC No dispute reported 06/30/2026 1248158502
Principal investigator 1 Janssen Research & Development, LLC $45,091.00 09/19/2025 Non-covered Recipient Entity
Arizona Crdvsclr Rsrch Fndtn
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175165032
Principal investigator 1 Janssen Research & Development, LLC $51,432.00 08/25/2025 Non-covered Recipient Entity
Arizona Crdvsclr Rsrch Fndtn
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175165393
Principal investigator 1 Abbott Laboratories $226.00 08/04/2025 Non-covered Recipient Entity
Arizona Arrhythmia Research Center
NCT04226547--Amplatzer Amulet LAAO vs. NOAC No dispute reported 06/30/2026 1248154952
Principal investigator 1 ZOLL Respicardia, Inc. $400.00 08/01/2025 Non-covered Recipient Entity
Arizona Heart Rhythm Research Center
ZOLL Respicardia, Inc. Registry Study No dispute reported 06/30/2026 1236585852
Principal investigator 1 ZOLL Respicardia, Inc. $1,680.00 08/01/2025 Non-covered Recipient Entity
Arizona Heart Rhythm Research Center
ZOLL Respicardia, Inc. Registry Study No dispute reported 06/30/2026 1236585866
Principal investigator 1 ZOLL Respicardia, Inc. $1,750.00 08/01/2025 Non-covered Recipient Entity
Arizona Heart Rhythm Research Center
ZOLL Respicardia, Inc. Registry Study No dispute reported 06/30/2026 1236585871
Principal investigator 1 ZOLL Respicardia, Inc. $446.00 07/24/2025 Non-covered Recipient Entity
Arizona Heart Rhythm Research Center
ZOLL Respicardia, Inc. Registry Study No dispute reported 06/30/2026 1236585862
Principal investigator 1 Janssen Research & Development, LLC $293,553.00 07/23/2025 Non-covered Recipient Entity
Arizona Crdvsclr Rsrch Fndtn
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175165166
Principal investigator 1 AstraZeneca Pharmaceuticals LP $67,180.80 06/27/2025 Non-covered Recipient Entity
ARIZONA CARDIOVASCULAR RESEARCH
A Phase III Randomised Doubleblind Study to Evaluate the Effect of Balcinrenone Dapagliflozin Compared with Dapagliflozin on the Risk of Heart Failure Events and Cardiovascular Death in Patients with Heart Failure and Impaired Kidney Function No dispute reported 06/30/2026 1185545319
Principal investigator 1 Janssen Research & Development, LLC $31,050.00 06/25/2025 Non-covered Recipient Entity
Arizona Crdvsclr Rsrch Fndtn
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175166172
Principal investigator 1 Abbott Laboratories $596.00 05/29/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT04226547--Amplatzer Amulet LAAO vs. NOAC No dispute reported 06/30/2026 1248151404
Principal investigator 1 Boston Scientific Corporation $1,500.00 05/27/2025 Covered Recipient Teaching Hospital
St. Josephs Hospital & Medical Ctr
OPTION No dispute reported 06/30/2026 1207580851
Principal investigator 1 Abbott Laboratories $3,184.00 05/14/2025 Non-covered Recipient Entity
Arizona Arrhythmia Research Center
NCT04226547--Amplatzer Amulet LAAO vs. NOAC No dispute reported 06/30/2026 1248150986
Principal investigator 1 ZOLL Respicardia, Inc. $884.00 04/23/2025 Non-covered Recipient Entity
Arizona Heart Rhythm Research Center
ZOLL Respicardia, Inc. Registry Study No dispute reported 06/30/2026 1236585858
Principal investigator 1 Eli Lilly and Company $13,954.00 04/01/2025 Non-covered Recipient Entity
ARIZONA ARRYTHMIA RESEARCH CENTER DBA ARIZONA CARDIOVASCULAR RESEARCH CENTER
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, EVENT-DRIVEN STUDY TO INVESTIGATE THE EFFECT OF RETATRUTIDE ON THE INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS AND THE DECLINE IN KIDNEY FUNCTION IN PARTICIPANTS WITH BODY MASS INDEX GREATER THAN 27 KG M2 AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE AND OR CHRONIC KIDNEY DISEASE No dispute reported 06/30/2026 1187873791
Principal investigator 1 Janssen Research & Development, LLC $78,351.00 02/19/2025 Non-covered Recipient Entity
Arizona Crdvsclr Rsrch Fndtn
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175165847
Principal investigator 1 Abbott Laboratories $1,479.00 01/29/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT04226547--Amplatzer Amulet LAAO vs. NOAC No dispute reported 06/30/2026 1248145060
Principal investigator 1 Abbott Laboratories $450.00 01/27/2025 Non-covered Recipient Entity
Arizona Arrhythmia Research Center
NCT04226547--Amplatzer Amulet LAAO vs. NOAC No dispute reported 06/30/2026 1248145054
Principal investigator 1 Janssen Research & Development, LLC $136,260.00 01/22/2025 Non-covered Recipient Entity
Arizona Crdvsclr Rsrch Fndtn
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175165772